The Impact of Multicultural Interfacility Video Case Conference: A Novel Education Model After the COVID Pandemic

Abstract
Context The coronavirus disease 2019 (COVID-19) pandemic challenged undertaking gradual educational activities for residency and fellowship trainees. However, recent technological advances have enabled broadening active learning opportunities through international online conferences. Objective The format of our international online endocrine case conference, launched during the pandemic, is introduced. The objective impact of this program on trainees is described. Methods Four academic facilities developed a semi-annual international collaborative endocrinology case conference. Experts were invited as commentators to facilitate in-depth discussion. Six conferences were held between 2020 and 2022. After the fourth and sixth conferences, anonymous multiple-choice online surveys were administered to all attendees. Results Participants included trainees and faculty. In each conference, 3-5 cases of rare endocrine diseases from up to 4 institutions were presented, mainly by trainees. Sixty-two percent of attendees reported 4 facilities as the appropriate size for the collaboration to maintain active learning in case conferences. Eighty-two percent of attendees preferred a semi-annual conference. The survey also revealed the positive impact on trainees’ learning regarding diversity of medical practice, academic career development, and confidence in honing of presentation skills. Conclusion We present an example of our successful virtual global case conference to enhance learning of rare endocrine cases. For the success of the collaborative case conference, we suggest smaller cross-country institutional collaborations. Preferably, they would be international, semi-annual based, and with recognized experts as commentators. Since our conference has engendered multiple positive impacts on trainees and faculty, continuation of virtual education should be considered even following the pandemic era.
Funding Information
  • SPS KAKENHI (19K09003)
  • National Institutes of Health (R01DK130378)